stockgist
HomeTop MoversCompaniesConcepts

Market

  • Top Movers
  • Companies
  • Concepts

SEC Filings

  • AI Filing Analysis
  • Financial Reports
  • Current Reports
  • IPO Filings

Ownership

  • Institutional Holdings
  • Insider Trading

About

  • Data updates every 5 min
  • SEC EDGAR Source
© 2025–2026 StockGist|Information only, not investment advice
    1. Filing Summaries
    stockgist
    HomeTop MoversCompaniesConcepts

    AI-Generated Filing Summaries

    AI-powered insights from 8-K, 6-K, 10-K and 10-Q filings with category and key takeaways

    Past 24 Hours

    Total

    0

    10-K

    0

    10-Q

    0

    8-K

    0

    6-K

    0

    13F

    0

    Other

    0

    Materiality:

    Showing 30 of 16187 summaries

    SafeSpace Global Corporation

    SSGC
    8-K

    Filing ID: 786794 • Mar 25, 2026, 9:10 AM ET

    Shareholder Vote on Authorized Share Increase
    HIGH
    5.07
    •

    Stockholders approved increase in authorized common shares from 200,000,000 to 300,000,000

    •

    Authorized 30,000,000 shares of blank check preferred stock

    •

    98.44% of votes cast (102,017,284 shares) in favor; 1.55% against

    SafeSpace Global Corporation stockholders approved via consent solicitation an amendment to its Certificate of Incorporation, increasing authorized common stock from 200,000,000 to 300,000,000 shares and authorizing 30,000,000 shares of blank check preferred stock. The approval enhances capital capacity for growth initiatives amid potential dilution risks.

    View Filing

    Tower Semiconductor Ltd.

    TSEM
    6-K

    Filing ID: 786793 • Mar 25, 2026, 9:10 AM ET

    Strategic Restructuring of Japan Operations and Planned 300mm Capacity Expansion
    HIGH
    •

    Tower to acquire full ownership of TPSCo's 300mm Fab 7 (Uozu) under a new wholly-owned Japanese subsidiary.

    •

    NTCJ (Nuvoton) to acquire full ownership of 200mm Fab 5.

    •

    Transaction targeted to close on April 1, 2027, subject to customary conditions and regulatory approvals.

    Tower Semiconductor announced a strategic restructuring of its Japan operations under TPSCo, taking full ownership of the 300mm Fab 7 facility while Nuvoton's NTCJ takes full ownership of the 200mm Fab 5, supported by mutual long-term supply agreements. The company plans to expand 300mm capacity up to four times current levels, contingent on METI subsidy approval, to meet strong demand in photonics and optical platforms.

    View Filing

    Next Technology Holding Inc.

    NXTT
    8-K

    Filing ID: 786803 • Mar 25, 2026, 9:20 AM ET

    Registered Direct Offering
    HIGH
    1.01
    •

    Entered Purchase Agreement on 2026-03-25 with twenty Purchasers

    •

    Issuing 71,381,818 Common Stock shares at $1.10 per share

    •

    Pre-Funded Warrants for 71,381,818 shares at $1.099 per warrant, exercisable at $0.001 per share

    Next Technology Holding Inc. entered into a securities purchase agreement on March 25, 2026, with twenty investors to issue and sell in a registered direct offering 71,381,818 shares of common stock at $1.10 per share and pre-funded warrants to purchase up to 71,381,818 shares at $1.099 per warrant, expecting approximately $157 million in gross proceeds for working capital.

    View Filing

    Trinity Biotech plc

    TRIB
    6-K

    Filing ID: 786802 • Mar 25, 2026, 9:20 AM ET

    Clinical Study Results and Commercialization Plans for Enhanced EpiCapture Prostate Cancer Test
    HIGH
    •

    Clinical study evaluated enhanced EpiCapture™ on approximately 750 patient samples

    •

    Test delivers 85% AUC clinical accuracy

    •

    Enhanced algorithm integrates machine learning, DNA biomarkers, and patient ethnicity

    Trinity Biotech plc announced successful clinical results for its enhanced EpiCapture™ prostate cancer test, achieving 85% AUC accuracy in a study of approximately 750 ethnically diverse patient samples using machine learning and patient ethnicity data. The company plans to commercialize the test as a Laboratory Developed Test through its New York reference laboratory, marking its entry into precision oncology diagnostics.

    View Filing

    USBC, Inc.

    USBC
    10-K

    Filing ID: 786814 • Mar 25, 2026, 9:30 AM ET

    •

    Net loss of -$27.5M for FY 2025 transition period.

    •

    Total operating expenses reached $17.1M.

    •

    Digital assets valued at $86.6M on balance sheet.

    USBC, Inc. reported a net loss of $27.5M for the fiscal year 2025 transition period ended December 31, 2025, compared to no prior year data provided in the filing. The loss was driven by a $17.1M operating loss from $17.1M total operating expenses, including $16.9M in selling, general, and administrative expenses and $254K in research and development. Other expenses netted -$26.1M, primarily a -$27.2M change in fair value of digital assets, partially offset by $1.1M other derivative income, $38K interest income, and a -$15.7M income tax benefit. No revenue was generated, reflecting the company's pre-revenue development stage focused on tokenized deposit offerings and Bitcoin treasury strategy. Balance sheet highlights include total assets of $93.7M, with $86.6M in digital assets and $6.8M current assets anchored by $4.1M cash. Stockholders' equity stood at $81.5M. Cash flows showed -$4.6M used in operations and a net -$4.7M decrease in cash. Forward-looking, USBC advances its USBC tokenized deposit pilot (Phase 1 initiated March 2026), partnerships with Uphold and Vast Bank, and Bitcoin yield generation via derivatives, positioning for future financial technology growth amid regulatory and market risks.

    View Filing

    OneMeta AI

    ONEI
    8-K

    Filing ID: 786813 • Mar 25, 2026, 9:30 AM ET

    Entry into First Amendment to Note and Warrant Purchase Agreement
    HIGH
    1.01
    •

    Entered First Amendment on March 17, 2026, effective Amendment Effective Date

    •

    Consolidated Existing Notes ($2 million principal) and Additional Notes ($200,000 principal) into $2.2 million aggregate principal Amended and Restated Notes

    •

    Maturity date: earlier of March 26, 2026 or Event of Default

    On March 17, 2026, OneMeta Inc. entered into a First Amendment to its October 31, 2025 Note and Warrant Purchase Agreement, consolidating $2 million Existing Notes and $200,000 Additional Notes into $2.2 million Amended and Restated Secured Convertible Promissory Notes maturing March 26, 2026. The amendment includes conversion options into common or preferred stock, 14% interest rate, subordination covenants, and most-favored-nation rights, impacting near-term liquidity and potential dilution.

    View Filing

    Fusion Fuel Green PLC

    HTOO
    6-K

    Filing ID: 786800 • Mar 25, 2026, 9:20 AM ET

    Press Release Highlighting Anticipated Uranium Royalty Acquisition
    MEDIUM
    •

    2.0% NSR royalty on Shea Creek project deposits (Kianna, Anne, Colette, 58B)

    •

    Shea Creek indicated resources: 67.57 million lbs U3O8 (2,056,000 tonnes at 1.49% U3O8)

    •

    Shea Creek inferred resources: 28.06 million lbs U3O8 (1,254,000 tonnes at 1.02% U3O8)

    Fusion Fuel Green PLC highlighted Royal Uranium Inc.'s anticipated 2.0% Net Smelter Return royalty on the Shea Creek uranium project, featuring 67.57 million lbs indicated and 28.06 million lbs inferred U3O8 resources operated by Orano Canada Inc. and Uranium Energy Corp. This is part of a 16-royalty portfolio to be acquired via the previously announced share exchange agreement.

    View Filing

    ENDRA Life Sciences Inc.

    NDRA
    8-K

    Filing ID: 786812 • Mar 25, 2026, 9:30 AM ET

    Strategic Alternatives Review and Workforce Reduction
    HIGH
    2.05
    7.01
    •

    Initiated strategic alternatives review on March 25, 2026, including potential mergers, investments, or sale of the Company

    •

    Reduced number of employees on March 19, 2026, to reduce cash expenditures

    •

    Expects $51,000 pre-tax cash charges for severance payments to former employees in Q1 2026

    ENDRA Life Sciences Inc. initiated a process to evaluate strategic alternatives, including mergers, asset sales, or business combinations, to maximize shareholder value, and engaged Lucid Capital Management and K&L Gates. On March 19, 2026, it reduced employees, expecting approximately $51,000 in pre-tax cash severance charges in Q1 2026 to extend its operational runway.

    View Filing

    Hesai Group

    HSAI
    6-K

    Filing ID: 786811 • Mar 25, 2026, 9:30 AM ET

    RSU Grants and Continuing Connected Transactions Framework Agreement
    MEDIUM
    •

    Granted 785,356 RSUs on March 25, 2026: 157,000 each to Dr. Yifan Li, Dr. Kai Sun, Mr. Shaoqing Xiang; 6,565 to Dr. Hui Wang; 307,791 to 70 employees.

    •

    Director RSUs to Dr. Li, Dr. Sun, Mr. Xiang vest over 48 months in four equal portions; Dr. Wang's vest over three years in three portions.

    •

    No performance targets for grants; subject to clawback and forfeiture provisions.

    Hesai Group granted 785,356 RSUs representing Class B Ordinary Shares to four directors and 70 employees on March 25, 2026, under the 2021 Plan to incentivize performance, retain talent, and align interests with shareholders. The company entered a Supply of Products Framework Agreement with connected person Sharpa to supply LiDAR products and robotic actuators from March 25 to December 31, 2026, with an annual cap of RMB100 million.

    View Filing

    Baozun Inc.

    BZUN
    6-K

    Filing ID: 786807 • Mar 25, 2026, 9:30 AM ET

    Announcement of the Fourth Quarter 2025 and Fiscal Year 2025 Results
    HIGH
    •

    Q4 total net revenues RMB3,172.2 million, +5.9% from RMB2,994.4 million same quarter 2024

    •

    Q4 GAAP income from operations RMB175.5 million, +139.8% from RMB73.2 million same quarter 2024, operating margin 5.5%

    •

    FY total net revenues RMB9,945.5 million, +5.6% from RMB9,422.2 million FY2024

    Baozun Inc. announced unaudited financial results for the fourth quarter and fiscal year ended December 31, 2025, with Q4 total net revenues of RMB3,172.2 million, up 5.9% year-over-year, and FY total net revenues of RMB9,945.5 million, up 5.6% year-over-year. Profitability improved significantly, including Q4 GAAP income from operations of RMB175.5 million, up 139.8% year-over-year, and positive FY GAAP operating income of RMB56.6 million.

    View Filing

    Waterdrop Inc.

    WDH
    6-K

    Filing ID: 786805 • Mar 25, 2026, 9:30 AM ET

    Q4 and FY 2025 Unaudited Financial Results and Cash Dividend
    HIGH
    •

    Q4 2025 net operating revenue RMB1,411.2 million (US$201.8 million), +105.5% YoY

    •

    Q4 2025 insurance-related income RMB1,310.4 million (US$187.4 million), +125.0% YoY

    •

    Q4 2025 operating profit RMB83.9 million (US$12.0 million), +58.4% YoY

    Waterdrop Inc. announced unaudited financial results for Q4 and FY 2025, with Q4 net operating revenue of US$201.8 million up 105.5% year-over-year and net profit attributable to ordinary shareholders of US$23.2 million. The company declared a cash dividend of approximately US$10.8 million and reported cumulative repurchases of 60.7 million ADSs for US$118.1 million as of end of February 2026.

    View Filing

    Baozun Inc.

    BZUN
    6-K

    Filing ID: 786806 • Mar 25, 2026, 9:30 AM ET

    Annual Results Announcement
    HIGH
    •

    Total net revenues RMB9,945.5 million (US$1,422.2 million), increase of 5.6% year-over-year

    •

    Service revenues RMB6,095.9 million (US$871.7 million), increase of 2.4% year-over-year

    •

    Income from operations RMB56.6 million (US$8.1 million) versus loss of RMB114.8 million in 2024

    Baozun Inc. announced unaudited consolidated annual results for the year ended December 31, 2025, with total net revenues of RMB9,945.5 million (US$1,422.2 million), up 5.6% year-over-year, and income from operations of RMB56.6 million (US$8.1 million) versus a loss of RMB114.8 million in 2024. Non-GAAP net income attributable to ordinary shareholders was RMB44.2 million (US$6.3 million).

    View Filing

    Mativ Holdings, Inc.

    MATV
    8-K

    Filing ID: 786809 • Mar 25, 2026, 9:30 AM ET

    Regulation FD Disclosure - Investor Presentation
    MEDIUM
    7.01
    •

    Event Type: Regulation FD Disclosure - Investor Presentation (Items: 7.01)

    Mativ Holdings, Inc. furnished an investor presentation under Item 7.01 providing an overview of trailing twelve-month financials, segment breakdowns, post-merger transformation progress including $65M+ synergies and facility reductions from 48 to 34, and planned capacity investments. This disclosure offers investors insights into current performance and strategic priorities.

    View Filing

    GSK plc

    GLAXF
    6-K

    Filing ID: 786808 • Mar 25, 2026, 9:30 AM ET

    Risk Factors Disclosure
    LOW
    •

    ITEM 3: D 'Risk factors' from 2025 Annual Report on Form 20-F

    •

    Registered in England & Wales No. 3888792

    •

    Registered Office: 79 New Oxford Street London WC1A 1DG

    GSK plc filed a Form 6-K on 2026-03-25 referencing ITEM 3: D 'Risk factors' in its Annual Report on Form 20-F for 2025. The filing includes the company's registration in England & Wales No. 3888792 and registered office at 79 New Oxford Street London WC1A 1DG.

    View Filing

    GSK plc

    GSK
    6-K

    Filing ID: 786808 • Mar 25, 2026, 9:30 AM ET

    Risk Factors Disclosure
    LOW
    •

    ITEM 3: D 'Risk factors' from 2025 Annual Report on Form 20-F

    •

    Registered in England & Wales No. 3888792

    •

    Registered Office: 79 New Oxford Street London WC1A 1DG

    GSK plc filed a Form 6-K on 2026-03-25 referencing ITEM 3: D 'Risk factors' in its Annual Report on Form 20-F for 2025. The filing includes the company's registration in England & Wales No. 3888792 and registered office at 79 New Oxford Street London WC1A 1DG.

    View Filing

    Ecopetrol S.A.

    EC
    6-K

    Filing ID: 786804 • Mar 25, 2026, 9:30 AM ET

    Board Response to Demands for President's Removal
    MEDIUM
    •

    Board meeting concluded March 24, 2026, discussing USO letter titled 'Request for Dr. Ricardo Roa Barragán to Be Removed from His Position as President of Ecopetrol'

    •

    Attorney General charges against President disclosed March 11, 2026

    •

    No breaches of credit agreements or material contracts as of March 25, 2026

    Ecopetrol S.A.'s Board of Directors, after meeting on March 24, 2026, addressed USO union's request, minority shareholders' queries, and an attorney's demand for President Ricardo Roa Barragán's removal amid formal charges by Colombia's Attorney General. The Board confirmed no regulatory violations, contract breaches, or securities authority notifications, with ongoing risk monitoring.

    View Filing

    La Rosa Holdings Corp.

    LRHC
    8-K

    Filing ID: 786815 • Mar 25, 2026, 9:40 AM ET

    Amendments to Securities Purchase Agreement and Token Right
    HIGH
    1.01
    •

    SPA Amendment allocates equity offering net proceeds: until $751,220.76 paid to Advisors (A.G.P./Alliance Global Partners and Curvature Securities LLC), 20% to fees, 40% to Note Purchased Crypto, 40% to corporate purposes.

    •

    Post-fee payment: 50% of equity proceeds to Note Purchased Crypto, 50% to corporate purposes including $77,000 additional Advisor fees due no earlier than December 31, 2026.

    •

    Company to reimburse Buyers and Advisors up to $65,000 in costs/legal fees from equity proceeds.

    La Rosa Holdings Corp. entered into an Amendment to its Securities Purchase Agreement (SPA) and an Amendment to the Token Right on March 24, 2026, with ATW AI Infrastructure III LLC and ATW AI Infrastructure IIIB LLC. The amendments detail allocation of net proceeds from equity offerings to advisor fees, Note Purchased Crypto acquisitions as treasury assets, and general corporate purposes including AI data center development, impacting capital deployment strategy.

    View Filing

    Aegon N.V.

    AEG
    6-K

    Filing ID: 786817 • Mar 25, 2026, 10:00 AM ET

    Supervisory Board Nomination
    MEDIUM
    •

    Aegon nominated Marco Keim to a.s.r. Supervisory Board to succeed Lard Friese.

    •

    Lard Friese stepping down following December 10, 2025 announcement to focus on Aegon relocation.

    •

    Vote at a.s.r. AGM on May 20, 2026; term to July 4, 2028 if approved.

    Aegon Ltd nominated Marco Keim, CEO of its International business and Executive Committee member, to succeed Lard Friese as non-independent member on the Supervisory Board of a.s.r., where Aegon holds a strategic 24% stake. The proposal will be voted on at a.s.r.'s AGM on May 20, 2026; if approved, Keim's term runs until July 4, 2028.

    View Filing

    Aegon N.V.

    AEFC
    6-K

    Filing ID: 786817 • Mar 25, 2026, 10:00 AM ET

    Supervisory Board Nomination
    MEDIUM
    •

    Aegon nominated Marco Keim to a.s.r. Supervisory Board to succeed Lard Friese.

    •

    Lard Friese stepping down following December 10, 2025 announcement to focus on Aegon relocation.

    •

    Vote at a.s.r. AGM on May 20, 2026; term to July 4, 2028 if approved.

    Aegon Ltd nominated Marco Keim, CEO of its International business and Executive Committee member, to succeed Lard Friese as non-independent member on the Supervisory Board of a.s.r., where Aegon holds a strategic 24% stake. The proposal will be voted on at a.s.r.'s AGM on May 20, 2026; if approved, Keim's term runs until July 4, 2028.

    View Filing

    Aegon N.V.

    AEGOF
    6-K

    Filing ID: 786817 • Mar 25, 2026, 10:00 AM ET

    Supervisory Board Nomination
    MEDIUM
    •

    Aegon nominated Marco Keim to a.s.r. Supervisory Board to succeed Lard Friese.

    •

    Lard Friese stepping down following December 10, 2025 announcement to focus on Aegon relocation.

    •

    Vote at a.s.r. AGM on May 20, 2026; term to July 4, 2028 if approved.

    Aegon Ltd nominated Marco Keim, CEO of its International business and Executive Committee member, to succeed Lard Friese as non-independent member on the Supervisory Board of a.s.r., where Aegon holds a strategic 24% stake. The proposal will be voted on at a.s.r.'s AGM on May 20, 2026; if approved, Keim's term runs until July 4, 2028.

    View Filing

    The Andersons, Inc.

    ANDE
    8-K

    Filing ID: 786816 • Mar 25, 2026, 9:50 AM ET

    Credit Agreement Amendment
    HIGH
    1.01
    2.03
    •

    Amendment completed March 20, 2026 to Credit Agreement with U.S. Bank National Association as Administrative Agent

    •

    Revolving credit facility reduced from $1.55 billion to $1.30 billion, maturity extended to March 20, 2031

    •

    Existing $114.3 million term loan maturity extended to March 20, 2031

    On March 20, 2026, The Andersons, Inc. completed an amendment to its Credit Agreement dated January 11, 2019, reducing the revolving credit facility capacity from $1.55 billion to $1.30 billion, extending maturities on revolving and term facilities to 2031 and 2034, and consolidating term loans into a $256.4 million facility. This restructures the company's debt profile and extends liquidity access.

    View Filing

    Honda Motor Co., Ltd.

    HNDAF
    6-K

    Filing ID: 786818 • Mar 25, 2026, 10:10 AM ET

    Joint Venture Business Direction Review and Financial Forecast Revision
    HIGH
    Guidance
    •

    Sony Honda Mobility discontinues development and launch of first model AFEELA1 and second model.

    •

    Honda and Sony to review SHM's future direction considering EV market changes.

    •

    Honda FY2026 consolidated operating profit forecast revised to -570,000 to -270,000 million yen from 550,000 million yen.

    Honda Motor Co., Ltd. and Sony Group Corporation announced a review of Sony Honda Mobility Inc.'s business direction, including discontinuation of development and launch of AFEELA1 and its second model, due to Honda's EV strategy reassessment. Honda expects immaterial impact on its FY ending March 31, 2026 consolidated financial forecasts, previously revised downward on March 12, 2026, to reflect expected losses of 820.0-1,120.0 billion yen in operating costs and 110.0-150.0 billion yen in equity method losses.

    View Filing

    Honda Motor Co., Ltd.

    HMC
    6-K

    Filing ID: 786818 • Mar 25, 2026, 10:10 AM ET

    Joint Venture Business Direction Review and Financial Forecast Revision
    HIGH
    Guidance
    •

    Sony Honda Mobility discontinues development and launch of first model AFEELA1 and second model.

    •

    Honda and Sony to review SHM's future direction considering EV market changes.

    •

    Honda FY2026 consolidated operating profit forecast revised to -570,000 to -270,000 million yen from 550,000 million yen.

    Honda Motor Co., Ltd. and Sony Group Corporation announced a review of Sony Honda Mobility Inc.'s business direction, including discontinuation of development and launch of AFEELA1 and its second model, due to Honda's EV strategy reassessment. Honda expects immaterial impact on its FY ending March 31, 2026 consolidated financial forecasts, previously revised downward on March 12, 2026, to reflect expected losses of 820.0-1,120.0 billion yen in operating costs and 110.0-150.0 billion yen in equity method losses.

    View Filing

    Lloyds Banking Group plc 9.25% NON-CUM IRR PRF SHS GBP0.25

    LLOBF
    6-K

    Filing ID: 786820 • Mar 25, 2026, 10:40 AM ET

    Redemption of Senior Notes
    MEDIUM
    •

    Redemption of entire $1,000,000,000 principal of 1.627% Senior Callable Fixed-to-Fixed Rate Notes due 2027 (CUSIP: 53944YAP8, ISIN: US53944YAP88) on 2026-05-11

    •

    Redemption Price: 100% principal plus accrued interest to but excluding Redemption Date

    •

    Trustee: The Bank of New York Mellon, London Branch

    Lloyds Banking Group plc announced the full redemption of its $1,000,000,000 1.627% Senior Callable Fixed-to-Fixed Rate Notes due 2027 on May 11, 2026, at 100% of principal plus accrued but unpaid interest. The NYSE listing of the Notes will be cancelled on or shortly after the Redemption Date, reducing outstanding debt.

    View Filing

    Lloyds Banking Group plc 9.25% NON-CUM IRR PRF SHS GBP0.25

    LLDTF
    6-K

    Filing ID: 786820 • Mar 25, 2026, 10:40 AM ET

    Redemption of Senior Notes
    MEDIUM
    •

    Redemption of entire $1,000,000,000 principal of 1.627% Senior Callable Fixed-to-Fixed Rate Notes due 2027 (CUSIP: 53944YAP8, ISIN: US53944YAP88) on 2026-05-11

    •

    Redemption Price: 100% principal plus accrued interest to but excluding Redemption Date

    •

    Trustee: The Bank of New York Mellon, London Branch

    Lloyds Banking Group plc announced the full redemption of its $1,000,000,000 1.627% Senior Callable Fixed-to-Fixed Rate Notes due 2027 on May 11, 2026, at 100% of principal plus accrued but unpaid interest. The NYSE listing of the Notes will be cancelled on or shortly after the Redemption Date, reducing outstanding debt.

    View Filing

    Lloyds Banking Group plc 9.25% NON-CUM IRR PRF SHS GBP0.25

    LYG
    6-K

    Filing ID: 786820 • Mar 25, 2026, 10:40 AM ET

    Redemption of Senior Notes
    MEDIUM
    •

    Redemption of entire $1,000,000,000 principal of 1.627% Senior Callable Fixed-to-Fixed Rate Notes due 2027 (CUSIP: 53944YAP8, ISIN: US53944YAP88) on 2026-05-11

    •

    Redemption Price: 100% principal plus accrued interest to but excluding Redemption Date

    •

    Trustee: The Bank of New York Mellon, London Branch

    Lloyds Banking Group plc announced the full redemption of its $1,000,000,000 1.627% Senior Callable Fixed-to-Fixed Rate Notes due 2027 on May 11, 2026, at 100% of principal plus accrued but unpaid interest. The NYSE listing of the Notes will be cancelled on or shortly after the Redemption Date, reducing outstanding debt.

    View Filing

    MainStreet Bancshares, Inc.

    MNSB
    8-K

    Filing ID: 786823 • Mar 25, 2026, 11:00 AM ET

    Subsidiary Bank Director Appointment
    MEDIUM
    7.01
    •

    Morgan Higgins appointed as Director of MainStreet Bank on March 25, 2026.

    •

    Ms. Higgins is Partner at Blue Delta Capital Partners, leading equity investments in government contracting businesses.

    •

    Prior to Blue Delta, Ms. Higgins was Executive Director at JP Morgan Chase, focusing on aerospace and government services banking.

    MainStreet Bancshares, Inc. issued a press release announcing the appointment of Morgan Higgins to MainStreet Bank's Board of Directors. Ms. Higgins brings over 20 years of experience in banking and government contracting, including roles at Blue Delta Capital Partners and JP Morgan Chase, to support the Bank's growth in defense and government services markets.

    View Filing

    MainStreet Bancshares, Inc.

    MNSBP
    8-K

    Filing ID: 786823 • Mar 25, 2026, 11:00 AM ET

    Subsidiary Bank Director Appointment
    MEDIUM
    7.01
    •

    Morgan Higgins appointed as Director of MainStreet Bank on March 25, 2026.

    •

    Ms. Higgins is Partner at Blue Delta Capital Partners, leading equity investments in government contracting businesses.

    •

    Prior to Blue Delta, Ms. Higgins was Executive Director at JP Morgan Chase, focusing on aerospace and government services banking.

    MainStreet Bancshares, Inc. issued a press release announcing the appointment of Morgan Higgins to MainStreet Bank's Board of Directors. Ms. Higgins brings over 20 years of experience in banking and government contracting, including roles at Blue Delta Capital Partners and JP Morgan Chase, to support the Bank's growth in defense and government services markets.

    View Filing

    Bluerock Homes Trust, Inc.

    BHM
    8-K

    Filing ID: 786821 • Mar 25, 2026, 10:50 AM ET

    Governance Disclosures (Part III Items 10-14 Incorporation)
    LOW
    •

    Filed Post-Effective Amendment No. 1 to Form S-11 (Reg. No. 333-290772) on March 12, 2026, including 2025 Form 10-K financials.

    •

    Executive officers include R. Ramin Kamfar (CEO, age 62), Jordan Ruddy (President, age 63), Ryan S. MacDonald (CIO, age 43).

    •

    Board of directors: R. Ramin Kamfar (Chairman/CEO), I. Bobby Majumder (Lead Independent), Elizabeth Harrison, Kamal Jafarnia, Romano Tio (all independent except Kamfar).

    Bluerock Homes Trust, Inc. filed this Form 8-K under Item 8.01 to incorporate by reference into its Form S-11 Registration Statement (effective December 10, 2025) and upcoming 2026 Proxy Statement certain Part III disclosures, including executive officers, board of directors, governance, director compensation, security ownership, related party transactions, and accountant fees. This updates the Registration Statement with audited 2025 financials and provides investor transparency on governance and affiliations.

    View Filing

    Sony Group Corporation

    SNEJF
    6-K

    Filing ID: 786825 • Mar 25, 2026, 11:10 AM ET

    Share Repurchase Conclusion
    MEDIUM
    •

    Total shares repurchased: 70,793,900 shares

    •

    Total purchase amount: 249,999,854,281 yen

    •

    Recent repurchase (March 1-24, 2026): 33,585,600 shares for 112,944,325,662 yen

    Sony Group Corporation announced the status and conclusion of its repurchase of common stock under board resolutions dated November 11, 2025, February 5, 2026, and February 26, 2026. As of March 24, 2026, Sony repurchased 70,793,900 shares for 249,999,854,281 yen via open market purchases on the Tokyo Stock Exchange.

    View Filing
    1...538540
    Go toof 540

    Market

    • Top Movers
    • Companies
    • Concepts

    SEC Filings

    • AI Filing Analysis
    • Financial Reports
    • Current Reports
    • IPO Filings

    Ownership

    • Institutional Holdings
    • Insider Trading

    About

    • Data updates every 5 min
    • SEC EDGAR Source
    © 2025–2026 StockGist|Information only, not investment advice